: AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail – VibeJiver

: AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail

Uncategorized

AZD7442 is being evaluated for the prevention and treatment of COVID-19 in late-stage trials in more than 9,000 participants around the world.

AZD7442 is being evaluated for the prevention and treatment of COVID-19 in late-stage trials in more than 9,000 participants around the world.